{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:30:55Z","timestamp":1788489055276,"version":"build-2803163510"},"reference-count":26,"publisher":"The Journal of Rheumatology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To study, in a real-life setting, the construct validity, the reliability, and the interpretability of the 12-item Psoriatic Arthritis Impact of Disease (PsAID-12) questionnaire in patients with psoriatic arthritis (PsA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>In 144 consecutive patients with PsA (81 men and 63 women, mean age of 51.4 \u00b1 12.8 yrs, and 77 receiving biologic treatment), the PsAID-12 and other patient-reported outcomes (PRO) were collected, such as the Dermatology Life Quality Index. Each patient underwent articular and skin assessment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Construct validity: Factor analysis revealed a 2-factor result defined as the PsAID Symptom Score and the PsAID Skin Score. In determining convergent validity, significant correlations were found between the PsAID-12 and the clinical Disease Activity index for Psoriatic Arthritis (cDAPSA; \u03c1 = 0.867, p &lt; 0.0001). Multivariable analysis showed that the PsAID-12 is determined by the articular disease activity (cDAPSA, p &lt; 0.0001), severity of psoriasis (PsO; physician\u2019s global assessment, p &lt; 0.0001), and the presence of a coexisting fibromyalgia (FM; p &lt; 0.0001). Reliability: Cronbach\u2019s alpha coefficient was 0.93 for the total PsAID-12. Interpretability: Applying the cDAPSA categorization of disease activity states, the PsAID-12 cutoff values resulted in 1.4 between remission and low disease activity (LDA), 4.1 between LDA and moderate disease activity (MDA), and 6.7 between MDA and high disease activity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>The PsAID-12 is an excellent PRO to evaluate the effect of PsA. It should be carefully handled in patients with coexisting FM.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.160924","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T02:20:24Z","timestamp":1480645224000},"page":"279-285","source":"Crossref","is-referenced-by-count":73,"title":["The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical Setting"],"prefix":"10.3899","volume":"44","author":[{"given":"Marco","family":"Di Carlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Becciolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Crotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennio Giulio","family":"Favalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Salaffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"2018112909364730000_44.3.279.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.11100"},{"key":"2018112909364730000_44.3.279.2","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-014-0065-0"},{"key":"2018112909364730000_44.3.279.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205207"},{"key":"2018112909364730000_44.3.279.4","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000129"},{"key":"2018112909364730000_44.3.279.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142901"},{"key":"2018112909364730000_44.3.279.6","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2018112909364730000_44.3.279.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.129379"},{"key":"2018112909364730000_44.3.279.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201341"},{"key":"2018112909364730000_44.3.279.9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.102053"},{"key":"2018112909364730000_44.3.279.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122259"},{"key":"2018112909364730000_44.3.279.11","doi-asserted-by":"crossref","first-page":"528105","DOI":"10.1155\/2014\/528105","article-title":"Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world","volume":"2014","author":"Salaffi","year":"2014","journal-title":"Biomed Res Int"},{"key":"2018112909364730000_44.3.279.12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200093"},{"key":"2018112909364730000_44.3.279.13","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20155"},{"key":"2018112909364730000_44.3.279.14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/TCRM.S101619","article-title":"The Psoriatic Arthritis Impact of Disease 12-item questionnaire: equivalence, reliability, validity, and feasibility of the touch-screen administration versus the paper-and-pencil version","volume":"12","author":"Salaffi","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"2018112909364730000_44.3.279.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972"},{"key":"2018112909364730000_44.3.279.16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05378.x"},{"key":"2018112909364730000_44.3.279.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.10993"},{"key":"2018112909364730000_44.3.279.18","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20140"},{"key":"2018112909364730000_44.3.279.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.23568"},{"key":"2018112909364730000_44.3.279.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.01.022"},{"key":"2018112909364730000_44.3.279.21","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0384-y"},{"key":"2018112909364730000_44.3.279.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.04.012"},{"key":"2018112909364730000_44.3.279.23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207507"},{"key":"2018112909364730000_44.3.279.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208274"},{"key":"2018112909364730000_44.3.279.25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00296-014-2955-9","article-title":"Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity","volume":"34","author":"Salaffi","year":"2014","journal-title":"Rheumatol Int"},{"key":"2018112909364730000_44.3.279.26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151491"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.160924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T23:24:38Z","timestamp":1718925878000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.160924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,1]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3899\/jrheum.160924"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.160924","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}